Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8776427rdf:typepubmed:Citationlld:pubmed
pubmed-article:8776427lifeskim:mentionsumls-concept:C0334246lld:lifeskim
pubmed-article:8776427lifeskim:mentionsumls-concept:C0460004lld:lifeskim
pubmed-article:8776427lifeskim:mentionsumls-concept:C0069717lld:lifeskim
pubmed-article:8776427lifeskim:mentionsumls-concept:C0034897lld:lifeskim
pubmed-article:8776427lifeskim:mentionsumls-concept:C0282460lld:lifeskim
pubmed-article:8776427lifeskim:mentionsumls-concept:C0205179lld:lifeskim
pubmed-article:8776427pubmed:issue4lld:pubmed
pubmed-article:8776427pubmed:dateCreated1996-10-28lld:pubmed
pubmed-article:8776427pubmed:languageenglld:pubmed
pubmed-article:8776427pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8776427pubmed:citationSubsetDlld:pubmed
pubmed-article:8776427pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8776427pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8776427pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8776427pubmed:statusMEDLINElld:pubmed
pubmed-article:8776427pubmed:monthJullld:pubmed
pubmed-article:8776427pubmed:issn0964-1955lld:pubmed
pubmed-article:8776427pubmed:authorpubmed-author:CappelaerePPlld:pubmed
pubmed-article:8776427pubmed:authorpubmed-author:CupissolDDlld:pubmed
pubmed-article:8776427pubmed:authorpubmed-author:DegardinMMlld:pubmed
pubmed-article:8776427pubmed:authorpubmed-author:KrakowskiIIlld:pubmed
pubmed-article:8776427pubmed:authorpubmed-author:FargeotPPlld:pubmed
pubmed-article:8776427pubmed:authorpubmed-author:BrienzaSSlld:pubmed
pubmed-article:8776427pubmed:issnTypePrintlld:pubmed
pubmed-article:8776427pubmed:volume32Blld:pubmed
pubmed-article:8776427pubmed:ownerNLMlld:pubmed
pubmed-article:8776427pubmed:authorsCompleteYlld:pubmed
pubmed-article:8776427pubmed:pagination278-9lld:pubmed
pubmed-article:8776427pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:8776427pubmed:meshHeadingpubmed-meshheading:8776427-...lld:pubmed
pubmed-article:8776427pubmed:meshHeadingpubmed-meshheading:8776427-...lld:pubmed
pubmed-article:8776427pubmed:meshHeadingpubmed-meshheading:8776427-...lld:pubmed
pubmed-article:8776427pubmed:meshHeadingpubmed-meshheading:8776427-...lld:pubmed
pubmed-article:8776427pubmed:meshHeadingpubmed-meshheading:8776427-...lld:pubmed
pubmed-article:8776427pubmed:meshHeadingpubmed-meshheading:8776427-...lld:pubmed
pubmed-article:8776427pubmed:meshHeadingpubmed-meshheading:8776427-...lld:pubmed
pubmed-article:8776427pubmed:meshHeadingpubmed-meshheading:8776427-...lld:pubmed
pubmed-article:8776427pubmed:meshHeadingpubmed-meshheading:8776427-...lld:pubmed
pubmed-article:8776427pubmed:year1996lld:pubmed
pubmed-article:8776427pubmed:articleTitlePhase II trial of oxaliplatin (L-OHP) in advanced, recurrent and/or metastatic squamous cell carcinoma of the head and neck.lld:pubmed
pubmed-article:8776427pubmed:publicationTypeLetterlld:pubmed
pubmed-article:8776427pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:8776427pubmed:publicationTypeClinical Trial, Phase IIlld:pubmed